Traws Pharma, Inc. — Director's Dealing 2017

Jun 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2017-06-12

Reporting Person: Hoffman Michael B (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-12	Stock Option (right to purchase)	$1.94	A	2000	Acquired	2027-06-12	Common Stock (2000)	Direct

Footnotes

F1: These options vest over one year from the grant date in 12 equal monthly installments.